Inflammatory Bowel Disease in Dogs — Welfare and Nutrition

Inflammatory bowel disease (IBD) in dogs causes chronic gastrointestinal discomfort and nutritional compromise, requiring dietary management and immunosuppressive therapy to achieve remission and good quality of life.

Key Facts

Canine IBD is a heterogeneous group of chronic intestinal inflammatory conditions — lymphoplasmacytic enteritis is most common
German Shepherds, Soft Coated Wheaten Terriers, and Basenjis are at elevated breed risk
Clinical signs include chronic vomiting, diarrhoea, weight loss, and protein-losing enteropathy in severe cases
Diagnosis requires intestinal biopsy — endoscopy under anaesthesia provides both diagnosis and staging
Dietary trials with novel protein or hydrolysed protein diets are first-line treatment for many dogs
Immunosuppressive therapy (prednisolone, azathioprine, cyclosporine) is required when diet alone is insufficient
Protein-losing enteropathy (PLE) — the most severe form — carries a guarded prognosis with 1-year survival rates of 30-60%

Welfare Considerations

Canine IBD creates chronic welfare harm through sustained gastrointestinal discomfort, nutritional compromise, and the unpredictability of disease flares. Dogs with uncontrolled IBD experience nausea, abdominal cramping, and diarrhoea that disrupts sleep, normal behaviour, and appetite. Weight loss from malabsorption creates the paradox of a dog that eats but cannot maintain condition — owners often see a thin, apparently hungry dog despite adequate feeding. The diagnostic process requires anaesthesia for endoscopic biopsy — a welfare cost that enables accurate diagnosis and appropriate treatment targeting. Dietary management with novel protein or hydrolysed protein diets achieves remission in approximately 50% of cases, avoiding the need for immunosuppression and its side effects. For cases requiring medication, careful dose management minimising corticosteroid burden while controlling inflammation improves quality of life substantially. Protein-losing enteropathy represents the most serious welfare challenge: hypoalbuminaemia causes peripheral oedema, ascites, and respiratory compromise that significantly diminishes quality of life and carries high mortality even with intensive treatment.

What You Can Do

Seek specialist gastroenterology referral for dogs with chronic vomiting, diarrhoea, or weight loss
Trial novel protein or hydrolysed protein diets before escalating to immunosuppression where appropriate
Monitor albumin and body weight regularly in dogs with IBD — declining values warrant treatment review
Use quality-of-life assessment tools to track whether treatment is adequately controlling symptoms
Support canine gastroenterology research through veterinary school foundations
Learn to recognise signs of PLE — rapid weight loss and swelling of limbs warrant urgent assessment